Hepatocellular carcinoma with extrahepatic adrenal metastasis: an atypical case report

Authors

  • Diptajit Paul Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India
  • Baljit Singh Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India
  • Rakesh Dhankhar Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India
  • Vivek Kaushal Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India

DOI:

https://doi.org/10.18203/issn.2454-2156.IntJSciRep20212395

Keywords:

Hepatocellular carcinoma, Right adrenal metastasis, Upper abdominal pain, Sorafenib

Abstract

Hepatocellular carcinoma with extrahepatic metastasis are a threat to public health worldwide. Lung, bones and abdominal lymph nodes are the major sites of metastasis from liver primary, adrenal metastasis being a less common site. Here we present an old male presented with upper abdominal pain diagnosed as advanced, unresectable hepatocellular carcinoma with right adrenal metastasis. Patient was treated with multi-kinase inhibitor sorafenib and outcome was acceptable with good patient compliance.

Metrics

Metrics Loading ...

Author Biographies

Diptajit Paul, Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India

Junior Resident, Department of Radiation Oncology, Pt B D Sharma PGIMS, Rohtak, Haryna, India

Baljit Singh, Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India

Senior Residet, Department of Radiation Oncology, Pt B D Sharma PGIMS, Rohtak, Haryana, India

Rakesh Dhankhar, Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India

Professor, Department of Radiation Oncology, Pt B D Sharma PGIMS, Rohtak, Haryana, India

Vivek Kaushal, Department of Radiation Oncology, Pt. B. D. Sharma PGIMS, Rohtak, Haryana, India

Senior Professor and Head, Department of Radiation Oncology, Pt B D Sharma PGIMS, Rohtak, Haryana, India

References

World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020: Population Fact Sheets: World. 2020. Available at: https://gco.iarc.fr/today/fact-sheets-populations. Accessed on 04 May 2020.

Marino D, Zichi C, Audisio M, Sperti E, Di Maio M. Second-line treatment options in hepatocellular carcinoma. Drugs Context. 2019;8:212577.

Rimassa L, Santoro A. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial. Expert Rev Anticancer Ther. 2009;9(6):739-45.

Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10(1):25-34.

Yamashita T, Kudo M, Ikeda K, Izumi N, Tateishi R, Ikeda M, et al. REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset. J Gastroenterol. 2020;55(1):113-22.

Uchino K, Tateishi R, Shiina S, Kanda, M, Masuzaki R., Kondo Y et al Hepatocellular carcinoma with extrahepatic metastasis. Cancer. 2011;117:4475-83.

Nugroho A, Lee KW, Lee KB, Kim HS, Kim H, Yi NJ, Suh KS. Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report. Ann Hepatobiliary Pancreat Surg. 2018;22(3):287-91.

Mao K, Wang J. Present treatment situation of hepatocellular carcinoma with extrahepatic metastasis. Zhonghua Wai Ke Za Zhi. 2019;57(6):466-70.

Downloads

Published

2021-06-22

Issue

Section

Case Reports